These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 20554567

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
    Colombo AL, Ngai AL, Bourque M, Bradshaw SK, Strohmaier KM, Taylor AF, Lupinacci RJ, Kartsonis NA.
    Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ.
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [Abstract] [Full Text] [Related]

  • 5. Caspofungin for invasive candidiasis at a tertiary care medical center.
    Zaas AK, Dodds Ashley ES, Alexander BD, Johnson MD, Perfect JR.
    Am J Med; 2006 Nov; 119(11):993.e1-6. PubMed ID: 17071169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA, Vazquez J, De Waele J, Betts R, Rotstein C, Nucci M, Pappas PG, Ullmann AJ.
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Caspofungin for the treatment of less common forms of invasive candidiasis.
    Cornely OA, Lasso M, Betts R, Klimko N, Vazquez J, Dobb G, Velez J, Williams-Diaz A, Lipka J, Taylor A, Sable C, Kartsonis N.
    J Antimicrob Chemother; 2007 Aug; 60(2):363-9. PubMed ID: 17526917
    [Abstract] [Full Text] [Related]

  • 12. Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study.
    Sipsas NV, Lewis RE, Raad II, Kontoyiannis DP.
    Int J Antimicrob Agents; 2009 Jul; 34(1):95-8. PubMed ID: 19251404
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efungumab and caspofungin: pre-clinical data supporting synergy.
    Hodgetts S, Nooney L, Al-Akeel R, Curry A, Awad S, Matthews R, Burnie J.
    J Antimicrob Chemother; 2008 May; 61(5):1132-9. PubMed ID: 18299636
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
    Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva JA, Garbino J, Yan JL, Aram J, Capparella MR, Conte U, Schlamm H, Swanson R, Herbrecht R.
    J Antimicrob Chemother; 2017 Aug 01; 72(8):2368-2377. PubMed ID: 28459966
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.
    Clin Infect Dis; 2007 Oct 01; 45(7):883-93. PubMed ID: 17806055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.